News

The ruling cleared the way for the pharma company to settle cases tied to the epidemic that caused more than 500,000 deaths The billionaire family […]

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using […]

FDA has received adverse event reports after patients used compounded semaglutide.

FDA provides consumers and industry with safety, regulatory and availability information for various drugs by drug class. From A to Z. Topics include: acetaminophen, estrogen, […]

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

NEXVIAZYME is an enzyme used for the treatment of patients 1 year of age and older with late-onset Pompe disease (LOPD).

The guidance describes FDA’s current recommendations regarding adjusting for covariates in statistical analysis of randomized clinical trials.

The next Cannabis Science Conference Fall meeting is soliciting a call for abstracts.

Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.

In July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck’s cetuximab (Erbitux) for treatment of metastatic colorectal cancer and head […]

Shots: The EC has granted marketing authorization for Epysqli, a biosimilar referencing Soliris (eculizumab) for the treatment of adult and children’s patients with PNH The […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending the approval of Ztalmy oral suspension for epileptic seizures associated with CDD in patients aged […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending Sogroya (qw) for the replacement of endogenous GH in children aged ≥3yrs. & adolescents with […]

Shots: The EC has granted marketing authorization for Epysqli, a biosimilar referencing Soliris (eculizumab) for the treatment of adult and children’s patients with PNH The […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending the approval of Ztalmy oral suspension for epileptic seizures associated with CDD in patients aged […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending Sogroya (qw) for the replacement of endogenous GH in children aged ≥3yrs. & adolescents with […]

Sun Pharma, India’s largest drugmaker, is looking at acquisitions to boost its specialty pipeline and strengthen emerging markets business. “Our focus on M&A will be […]

Since I wrote that blog entry on the re-evaluation of the Wasserman catenane synthesis, I’ve had the pleasure of hearing from Ed Wasserman himself (via […]

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Animal Drugs/Adulterated  

Shots: Gregory initially spoke about the Attralus licensing agreement with Ossianix’s brain shuttle technology to enhance the targeted delivery of novel pan-amyloid removal candidates for […]

Shots: Gregory initially spoke about the Attralus licensing agreement with Ossianix’s brain shuttle technology to enhance the targeted delivery of novel pan-amyloid removal candidates for […]

Esto es lo que los expertos saben (y no saben) sobre esta afección desconcertante.

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet

Compounding Pharmacy/Adulterated Drug Products

If federal lawmakers don’t vote to raise the debt limit by early June, these FDA actions could be impacted.

Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.

Shots: The EC has granted marketing authorization for Epysqli, a biosimilar referencing Soliris (eculizumab) for the treatment of adult and children’s patients with PNH The […]

The EMA’s human medicines committee concluded that the benefits of Adakveo did not outweigh its risks

The drug has already been approved for this indication in the EU, with regulatory reviews continuing elsewhere including in the US

Shots: Sun Pharma to get an exclusive right to commercialize Nidlegy (developed by Philogen), a new anti-cancer biopharmaceutical drug for skin cancers in the territories […]

Esto es lo que los expertos saben (y no saben) sobre esta afección desconcertante.

Reconciliation is about strengthening relationships between First Nations and non-First Nations peoples, for the benefit of all Australians. First Nations health and medical research experts […]

Sun Pharmaceutical Industries on Tuesday said it has entered into a licensing pact with Philogen SpA to commercialise under-development skin cancer drug in Europe, Australia […]

ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original […]

Jubilant Pharmova Ltd on Tuesday announced leadership changes and board composition with Priyavrat Bhartia being appointed as Managing Director with incumbent Co-Chairman & Managing Director […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending the approval of Ztalmy oral suspension for epileptic seizures associated with CDD in patients aged […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending the approval of Ztalmy oral suspension for epileptic seizures associated with CDD in patients aged […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending Sogroya (qw) for the replacement of endogenous GH in children aged ≥3yrs. & adolescents with […]

Shots: The EMA’s CHMP has adopted a positive opinion recommending Sogroya (qw) for the replacement of endogenous GH in children aged ≥3yrs. & adolescents with […]

Shots: The MHLW has approved Ultomiris (C5 complement inhibitor) for the prevention of relapses in patients with AQP4 Ab+ neuromyelitis optica spectrum disorder (NMOSD) incl. […]

Shots: The MHLW has approved Ultomiris (C5 complement inhibitor) for the prevention of relapses in patients with AQP4 Ab+ neuromyelitis optica spectrum disorder (NMOSD) incl. […]

By Kevin E. Noonan — On April 26th, Ambassador Katherine Tai, U.S. Trade Representative (USTR), issued the 2023 Special 301 Report. In a press release, […]

NUZYRA (omadacycline tosylate) Paratek pharms inc Patent: 7,553,828 Expiration: Jun 2, 2023 See More … For more information on how DrugPatentWatch can help with your […]

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to […]

Do you face challenges when it comes to smaller production quantities, more specialization and many product creations. Flexibility is the answer. With the help of […]

In order to achieve the desired properties in a solid medicinal product, a granulate must be optimally prepared. Did you know that you can have […]

Do you face challenges when it comes to smaller production quantities, more specialization and many product creations. Flexibility is the answer. With the help of […]

“A presentation was made to the PMO in this regard and the concern of the Laghu Udyog Bharati was also discussed. A decision is likely […]

Government-owned company Genomics England has partnered with bioinformatics firm Seqera Labs to advance cancer care in the NHS.

The lack of regulatory clarity is imperiling India’s online pharmacy sector. While the digital business has grown rapidly in the past few years, online pharmacies […]

The lack of regulatory clarity is imperiling India’s online pharmacy sector. While the digital business has grown rapidly in the past few years, online pharmacies […]

Shots: David first talked about Clarivate’s Highly Cited Researchers 2022 list. He said that the list picks out 6,938 individuals at universities, research institutes, and […]

Shots: The EMA’s CHMP adopted the positive opinion recommending the approval of Opdivo + Pt-based CT for resectable NSCLC who are at a high risk […]

Shots: The EMA’s CHMP adopted the positive opinion recommending the approval of Opdivo + Pt-based CT for resectable NSCLC who are at a high risk […]

Shots: The companies collaborated to discover & develop novel therapies for patients with neurodegenerative diseases incl. Parkinson’s disease The collaboration will combine companies’ expertise and […]

Shots: The US FDA has accepted the BLA for lifileucel to treat patients with advanced melanoma & granted Priority Review with an expected PDUFA on […]

Shots: The P-III trial evaluating Imfinzi + Pt-based CT, followed by Imfinzi with Lynparza or Imfinzi alone as maintenance therapy vs Pt-based CT alone in […]

Shots: The P-III trial evaluating Imfinzi + Pt-based CT, followed by Imfinzi with Lynparza or Imfinzi alone as maintenance therapy vs Pt-based CT alone in […]

Shots: The P-III study evaluating Reblozyl vs epoetin alfa for anemia in 363 adult patients with very low, low, or intermediate-risk MDS who require RBC […]

This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent […]

The Delhi High Court has granted six weeks’ time to the Centre to inform it about the outcome of consultations and deliberations with stakeholders on […]

The Delhi High Court has granted six weeks’ time to the Centre to inform it about the outcome of consultations and deliberations with stakeholders on […]

This chart shows the patent expirations for capsule dosed drugs over the next decade. The term of drug patents varies. The basic term for a […]

The chemists’s body has alleged that no further action has been taken, despite notices being served on various online pharmacies by the Drug Controller General […]

The chemists’s body has alleged that no further action has been taken, despite notices being served on various online pharmacies by the Drug Controller General […]

The chemists’s body has alleged that no further action has been taken, despite notices being served on various online pharmacies by the Drug Controller General […]

The chemists’s body has alleged that no further action has been taken, despite notices being served on various online pharmacies by the Drug Controller General […]

Sean Hart, CEO and SCO of LumaCyte, discusses rapid accurate mRNA potency assay possibilities.

“We are excited to adopt this new identity that is a culmination of our efforts on brand transformation over the past few years,” said K. […]

“We are excited to adopt this new identity that is a culmination of our efforts on brand transformation over the past few years,” said K. […]

“We are excited to adopt this new identity that is a culmination of our efforts on brand transformation over the past few years,” said K. […]

“We are excited to adopt this new identity that is a culmination of our efforts on brand transformation over the past few years,” said K. […]

This chart shows the drugs with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) […]

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Shots: The approval was based on the P-III trial (QuANTUM-First) published in The Lancet evaluating Vanflyta + CT & as maintenance monotx. following consolidation vs […]

Shots: The approval was based on the P-III trial (QuANTUM-First) published in The Lancet evaluating Vanflyta + CT & as maintenance monotx. following consolidation vs […]

Netskope’s Damian Chung outlines how healthcare organizations can avoid cyber risks when executing acquisitions or partnerships.

Researchers have developed a nanorobot system that targets fungal infections in the mouth.

The first protein-based nano-computing agent that functions as a circuit has been created. The milestone puts them one step closer to developing next-generation cell-based therapies […]

Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the […]

Challenges to approval decisions have prompted FDA officials to reexamine of the role and composition of the agency’s many advisory committees and to explore options […]

The FDA is requiring updates to the Boxed Warning and other information to ensure the prescribing information is made consistent across the entire class of […]

The first patients with psoriasis have been dosed with a new drug to help combat the inflammatory skin disease in a clinical trial in China.

Abbreviated New Drug Applications and following the path to generic drug approval. Generic drug applications are termed “abbreviated” because they are generally not required to […]

“India played a phenomenal role in meeting the requirements of not just its domestic but needs of many others under unprecedented circumstances,” Mandaviya said. India’s […]

“India played a phenomenal role in meeting the requirements of not just its domestic but needs of many others under unprecedented circumstances,” Mandaviya said. India’s […]

“India played a phenomenal role in meeting the requirements of not just its domestic but needs of many others under unprecedented circumstances,” Mandaviya said. India’s […]

“India played a phenomenal role in meeting the requirements of not just its domestic but needs of many others under unprecedented circumstances,” Mandaviya said. India’s […]

Gilead Receives EMA’s CHMP Positive Opinion to Extend the Use of Veklury (remdesivir) for COVID-19 Date: May 26, 2023 | Tags: Gilead, Veklury, remdesivir, COVID-19, […]

High court rules there is insufficient new evidence of causal link between hormone-based test and birth defects An attempt by more than 100 UK families […]

Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

The Health Technology Assessment (HTA) Chairs Committee will advise on HTA investments under the Medical Research Future Fund (MRFF).

Shots: The EMA’s CHMP has granted a positive opinion for the use of Veklury (remdesivir) in COVID-19 patients with sev. renal impairment, incl. those on […]

Shots: The EMA’s CHMP has granted a positive opinion for the use of Veklury (remdesivir) in COVID-19 patients with sev. renal impairment, incl. those on […]

Therapy has been developed for use among children and adolescents with growth hormone deficiency

Life Sciences Council meeting hosted by chancellor Jeremy Hunt has unfolded in Downing Street

A drug that has the ability to âtransform the landscapeâ for people living with metastatic colorectal cancer (CRC) has been granted priority review by the […]

Shots: Akebia will receive $10M up front, ~$100M in commercial milestones for rights to Vafseo in the EU & Australia along with royalty up to […]

Shots: The approval was based on the P-III trial (QuANTUM-First) published in The Lancet evaluating Vanflyta + CT & as maintenance monotx. following consolidation vs […]

Shots: The approval was based on the P-III trial (QuANTUM-First) published in The Lancet evaluating Vanflyta + CT & as maintenance monotx. following consolidation vs […]

Shots: The final pre-specified OS analysis results from the P-III CLEAR (Study 307)/(KEYNOTE-581) trial evaluating Keytruda (200mg, IV, q3w for ~24mos.) + Lenvima (20mg, qd) […]

Shots: The updated results from 2 P-II expansion dose cohorts of the P-I/II trial evaluating linvoseltamab (BCMAxCD3 bispecific Ab). At recommended 200mg dose in the […]

  Curavax Pharmaceuticals Pvt Ltd Address : Khasra no. 8//6, 15/1, Plot no.8 Kuldeep Nagar, Ambala Cantt WHO, GMP & ISO 9001:2015 Certifications. We have pan […]

Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from […]

Annual Drug Patent Expirations for TRIKAFTA+%28COPACKAGED%29 Trikafta (copackaged) is a drug marketed by Vertex Pharms Inc and is included in one NDA. It is available […]

Annual Drug Patent Expirations for MONOFERRIC Monoferric is a drug marketed by Pharmacosmos As and is included in one NDA. It is available from one […]

This chart shows the drugs with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) […]

[Federal Register Volume 88, (Friday, May 26, 2023 )] [Notice] [Pages 34188-34190] The Standard on Presence Sensing Device Initiation (PSDI); Extension of the Office of […]

[Federal Register Volume 88, (Friday, May 26, 2023 )] [Notice] [Pages 34186-34188] The Construction Fall Protection Systems Criteria, Practices, and Training Requirements Standard; Extension of […]

[Federal Register Volume 88, (Friday, May 26, 2023 )] [Notice] [Pages 34188] Advisory Committee on Construction Safety and Health (ACCSH)

This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.

All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so […]

All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so […]

All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so […]

All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so […]

All medical devices will have to bear details like retail price, country of origin, size and dimensions and consumer care details on the package so […]

A new tool which could help reduce the spread of antimicrobial resistance is showing early promise, through exploiting a bacterial immune system as a gene […]

FDA has approved the first topical gene therapy product for treating wounds in patients with dystrophic epidermolysis bullosa.

FDA has approved AbbVie’s EPKINLY (epcoritamab-bysp), a bispecific antibody for treating relapsed or refractory diffuse large B-cell lymphoma.

List of Top 50 Pharma Companies in India 2023 The Indian pharmaceutical industry is one of the largest in the world, and it is growing […]

The pharmaceutical industry in Australia is a large and growing sector. In 2022, the industry was worth over $30 billion and employed over 100,000 people. […]

Andrea Lodetti, CEO of Bormioli Pharma, an Italian pharma primary packaging manufacturer, speaks about his company’s approach to the US market, supply chain instabilities, sustainability, […]

I noticed a headline this morning that BenevolentAI is laying off staff and reorganizing to deal with a recent clinical failure. I’ve written about them […]

Banks Bourne, sole owner of Tanner Pharma in North Carolina, took sum from Tanner’s UK arm, records show An American banker was paid a £73m […]

The FDA approved oral antiviral Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including […]

Global Healthcare Opportunities (GHO) Capital Partners LLP along with Partners Group has announced today (May 25) that it has invested an undisclosed amount in GHO […]

FDA scientists carry out laboratory, clinical and analytical research to address knowledge gaps in drug development, healthcare technologies and post-market drug monitoring. Spotlight on CDER […]

H1, a US data healthcare data technology company has been selected by non-profit funder of Parkinsonâs Disease (PD) research, The Michael J Fox Foundation (MJFF), […]

A company developing small molecule therapeutics targeting DNA Damage Response (DDR) in order to treat patients with a broad range of cancers has its first […]

Insights+: EMA Marketing Authorization of New Drugs in April 2023 Shots: The EMA approved 8 New Chemical Entity (NCE) and 3 Biologic Drugs in April […]

Frequently asked questions and the associated answers sorted by topic area

Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products; Draft Guidance for Industry; Availability

Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products

The two institutional battles offer a glimpse into the tension between pharma innovation and regulation that could reverberate across the industry.

Shots: The companies expand their collaboration for an additional two years to develop novel cancer immunotherapies. OBT will receive research funding & success-based development and […]

Shots: The company presented the data at ESC 2023 & published in The Lancet from an investigator-sponsored EU (MONITOR-HF) trial evaluating the CardioMEMS HF system […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

The company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovation, supply localisation, and […]

Shots: ClearPoint Neuro is eligible to receive success-based milestones. The companies’ focus is to develop drug delivery platforms for Belgian biopharma’s gene therapy portfolio The […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and […]

The collaboration aims to develop novel preclinical models with a view to identifying new treatments

Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. In March, Sun Pharma also reported […]

Shots: The P-I trial (INSIGHT-003) evaluating eftilagimod alpha (soluble LAG-3 protein & MHC Class II agonist) + SoC anti-PD-1 therapy & doublet CT. The trial […]

Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar referencing Humira for the treatment of 8 conditions: RA, JIA, PsA, AS, CD, […]

Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar referencing Humira for the treatment of 8 conditions: RA, JIA, PsA, AS, CD, […]

Annual Drug Patent Expirations for ELUCIREM Elucirem is a drug marketed by Guerbet and is included in one NDA. It is available from two suppliers. […]

Annual Drug Patent Expirations for SYMDEKO+%28COPACKAGED%29 Symdeko (copackaged) is a drug marketed by Vertex Pharms Inc and is included in one NDA. It is available […]

Annual Drug Patent Expirations for DILAUDID Dilaudid is a drug marketed by Fresenius Kabi Usa and Rhodes Pharms and is included in three NDAs. It […]

Annual Drug Patent Expirations for SELZENTRY Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two […]

Annual Drug Patent Expirations for DILAUDID-HP Dilaudid-hp is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from […]

This chart shows the drugs with the most patents in China. Patents must be filed in each country (or, in some cases regional patent office) […]

CPHI Barcelona will feature programs on next-gen biomanufacturing, manufacturing 4.0, quality management fundamentals, and more.

Connect in Pharma is a European conference designed to drive future innovations in pharma and biotech packaging, medical devices, and manufacturing.

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in early phase development, the role of CDMOs, and highlight the benefits and […]

Engineers have designed a new class of ‘microrobots’ several times smaller than the width of a human hair that may be able to treat human […]

A new study has shown that human T cells have an important role to play in controlling infection.

Tau protein is implicated in many neurogenerative diseases, including Alzheimer’s. New findings point to a new potential drug target to slow the progress of the […]

Recent research has identified a new compound that can stimulate nerve regeneration after injury, as well as protect cardiac tissue from the sort of damage […]

Guidance Recap Podcast | Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers

The new CGMP facility is expected to contribute to the development of mRNA therapeutics, with a building designed for the CGMP manufacture of mRNA-based in-vivo […]

Blueprint Medicines’ avapritinib has been approved by FDA for the treatment of indolent systemic mastocytosis.

Unapproved New Drugs/Misbranded

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Unapproved New Drugs/Misbranded

Ironwood Pharmaceuticals’ acquisition of VectivBio grants it the rights to apraglutide, a glucagon-like peptide being evaluated for gastrointestinal diseases.

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Comprehensive List of Pharma Companies in Hyderabad At the Pharma job portal, we take pride in providing you with the most comprehensive and up-to-date information […]

Introduction Welcome to our comprehensive guide on understanding the difference between bulk density and tapped density. At PharmaJobPortal.com, we are dedicated to providing valuable insights […]

Different Types of Deviations in Pharmaceutical Industry In the fast-paced and highly regulated pharmaceutical industry, ensuring quality and compliance is of utmost importance. However, despite […]

The facility is based on a state-of-the-art design concept that allows maximum flexibility for a multi-product, multi-platform offering.

OK, there’s a lot of stuff going on out there in biopharma, but as for me, I’m going to take a day to talk about […]

According to sources, the issue was discussed at length in the meeting and the Department suggested them to explore new packing technology for medicines. A […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

Chemists say giving away a few pills from a blister pack gives rise to the problem of the remaining portion of the pack not having […]

The U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)

FDA is accepting requests to participate in the DSCSA pilot project program until March 11, 2019.

Shots: In continuation of our previous series on the top-performing drug of the month, based on 2021 revenue, this month we have covered Trikafta/Kaftrio as […]

Shots: In continuation of our previous series on the top-performing drug of the month, based on 2021 revenue, this month we have covered Trikafta/Kaftrio as […]

Alvotech and Advanz Pharma have signed a strategic partnership agreement for the supply and commercialization of five biosimilar candidates in Europe.

Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information

UK government supports AMR research with significant cash injection, provided through the Global AMR Innovation Fund (GAMRIF).

ILC Therapeutics has entered into a strategic partnership with Dechra Pharmaceuticals to develop an atopic dermatitis treatment for dogs.

As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

VizGen’s CEO discusses the potential of spatial genomics in the life sciences and the company’s role in the movement.

Shots: Advanz Pharma gets an exclusive right from Alvotech to commercialize five proposed biosimilars in the EU. Alvotech will be responsible for the development and […]

Celadon will sell a minimum of £3m worth of the high-THC product over the next three years

Vital data supports early intervention in order to treat chronic obstructive pulmonary disease

Shots: CohBar shareholders will receive a dividend of 3.30 shares of CohBar common stock & pre-merger CohBar shareholders will receive a CVR related to the […]

Shots: The first patient has been dosed in the P-II trial (GALARISSO) evaluating the efficacy, safety, tolerability, PK & PD of GLPG3667 (150mg, qd) vs […]

Shots: The US FDA has granted RMAT designation to RGX-121, an investigational one-time AAV therapeutic for MPS II also known as Hunter syndrome RGX-121 is […]

Shots: The US FDA has granted RMAT designation to RGX-121, an investigational one-time AAV therapeutic for MPS II also known as Hunter syndrome RGX-121 is […]

Davis, California – Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade […]

Shots: The (PIONEER) trial evaluating Ayvakit (25mg, qd) + BSC vs PBO + BSC in 212 patients showed rapid, durable & reductions in all measures […]